Projects

Sputum transcriptomics and serum cytokine profile to identify novel biomarkers to distinguish tobacco smoke and biomass fuel associated chronic obstructive pulmonary disease

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2019 - 2021

Project Lead

Dr Uma

Authors

Dr Uma M, Dr Sweta S, Dr Kavitha V

Project Status

completed

Project Type

Co-PI